Quest Diagnostics Inc Advertising Expense
Quest Diagnostics Inc (DGX) reported Advertising Expense of $35.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-02-26
- Quest Diagnostics Inc advertising expense for fiscal 2025 was $35.00M, a 25.00% increase from fiscal 2024.
- Quest Diagnostics Inc advertising expense for fiscal 2024 was $28.00M, a 9.68% decline from fiscal 2023.
- Quest Diagnostics Inc advertising expense for fiscal 2023 was $31.00M, a 58.11% decline from fiscal 2022.
- Quest Diagnostics Inc advertising expense for fiscal 2022 was $74.00M, a 5.13% decline from fiscal 2021.
| Period end | Advertising Expense 12 month |
|---|---|
| 2025-12-31 | $35.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $28.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $31.00M 10-K · filed 2026-02-26 |
| 2022-12-31 | $74.00M 10-K · filed 2025-02-20 |
| 2021-12-31 | $78.00M 10-K · filed 2024-02-22 |
| 2020-12-31 | $38.00M 10-K · filed 2023-02-21 |
| 2019-12-31 | $18.00M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |